43.97
전일 마감가:
$43.49
열려 있는:
$43.49
하루 거래량:
643.90K
Relative Volume:
1.42
시가총액:
$1.97B
수익:
$1.15B
순이익/손실:
$23.09M
주가수익비율:
87.94
EPS:
0.5
순현금흐름:
$89.18M
1주 성능:
+8.62%
1개월 성능:
+19.45%
6개월 성능:
+40.75%
1년 성능:
-6.72%
옴니셀 Stock (OMCL) Company Profile
명칭
Omnicell Inc
전화
(877) 415-9990
주소
4220 NORTH FREEWAY, FORT WORTH
OMCL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
OMCL
Omnicell Inc
|
43.97 | 1.95B | 1.15B | 23.09M | 89.18M | 0.50 |
|
VEEV
Veeva Systems Inc
|
229.16 | 38.14B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
75.07 | 13.50B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
45.04 | 8.50B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
95.73 | 7.97B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
35.20 | 6.39B | 11.99B | 24.18M | 234.31M | 0.2956 |
옴니셀 Stock (OMCL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-14 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-08-02 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-01-03 | 개시 | Barclays | Underweight |
| 2023-11-03 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-11-03 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | 재확인 | Wells Fargo | Underweight |
| 2023-08-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | 다운그레이드 | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2022-11-03 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | 개시 | BofA Securities | Buy |
| 2022-07-15 | 개시 | SVB Leerink | Mkt Perform |
| 2021-12-06 | 재개 | Wells Fargo | Overweight |
| 2021-06-09 | 개시 | JP Morgan | Neutral |
| 2021-05-24 | 개시 | BTIG Research | Buy |
| 2021-02-02 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | 개시 | Berenberg | Buy |
| 2020-12-03 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | 개시 | Stephens | Overweight |
| 2020-02-07 | 재확인 | Dougherty & Company | Buy |
| 2019-11-21 | 재확인 | Dougherty & Company | Buy |
| 2019-07-26 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2019-03-07 | 재확인 | Dougherty & Company | Buy |
| 2018-06-29 | 재개 | The Benchmark Company | Buy |
| 2017-09-05 | 재확인 | The Benchmark Company | Buy |
| 2017-07-28 | 재확인 | Dougherty & Company | Buy |
| 2017-04-21 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | 개시 | Dougherty & Company | Buy |
| 2016-12-06 | 재확인 | The Benchmark Company | Buy |
| 2016-07-07 | 재확인 | FBR Capital | Outperform |
| 2016-03-21 | 재확인 | Topeka Capital Markets | Buy |
| 2016-01-07 | 개시 | The Benchmark Company | Buy |
| 2015-11-16 | 재확인 | Topeka Capital Markets | Buy |
| 2015-10-30 | 재확인 | FBR Capital | Outperform |
| 2015-09-28 | 업그레이드 | Sidoti | Neutral → Buy |
| 2015-07-31 | 재확인 | Topeka Capital Markets | Buy |
모두보기
옴니셀 주식(OMCL)의 최신 뉴스
Is Omnicell (OMCL) Expanding OmniSphere Into Nursing Units Enough To Reinforce Its Moat? - Yahoo Finance
Pharmacy Automation Systems Market to Reach US$ 12.05 Billion - openPR.com
Omnicell stock price target raised by BofA to $46 on new cabinet launch - Investing.com UK
Health Systems Embrace New Strategies to Navigate Disruptions - 富途牛牛
Benchmark raises Omnicell stock price target to $50 on new Titan XT system - Investing.com Canada
Omnicell (OMCL) Analyst Maintains 'Buy' Rating, Raises Price Tar - GuruFocus
Omnicell stock rises after launch of enterprise-level medication dispensing system - Investing.com Nigeria
Omnicell Launches Advanced Titan XT Dispensing System - TipRanks
Omnicell launches Titan XT automated dispensing system for hospitals By Investing.com - Investing.com South Africa
Omnicell, Inc. Launches Omnicell Titan XT Automated Dispensing System - TradingView
Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management - Yahoo Finance
Omnicell (OMCL) Valuation Check After Recent Share Price Rebound - Yahoo Finance
1 Healthcare Stock with Impressive Fundamentals and 2 We Brush Off - Markets Financial Content
Insider Sell: Corey Manley Sells Shares of Omnicell Inc (OMCL) - GuruFocus
Omnicell EVP & Chief Legal/Admin Officer Sells Shares - TradingView
Reasons to Add Omnicell Stock to Your Portfolio Right Now - Nasdaq
Why Omnicell Inc. (OC9) stock is favored by hedge fundsForecast Cut & Real-Time Volume Spike Alerts - Newser
Will Omnicell Inc. stock outperform tech sector in 2025Trade Volume Summary & Fast Moving Market Watchlists - Newser
Why Omnicell Inc stock could rally in 2025Market Performance Recap & Verified Short-Term Trading Plans - BỘ NỘI VỤ
Is Omnicell Inc. (OC9) stock undervalued at current price2025 Key Highlights & Daily Profit Maximizing Trade Tips - Newser
Is Omnicell Inc. (OC9) stock a good hedge against inflationTrade Analysis Report & Verified Swing Trading Watchlist - Newser
Why Omnicell Inc. (OC9) stock stays resilient2025 Price Momentum & Weekly High Return Stock Forecasts - Newser
Systematic Financial Management LP Acquires New Stake in Omnicell, Inc. $OMCL - MarketBeat
Will Omnicell Inc. (OC9) stock sustain uptrend momentum2025 Investor Takeaways & Verified Momentum Stock Alerts - Newser
Prudential Financial Inc. Cuts Stock Position in Omnicell, Inc. $OMCL - MarketBeat
VP Manley Files To Sell 6,106 Of Omnicell Inc [OMCL] - TradingView
Omnicell Chairman and CEO Randall A. Lipps Sells 28,250 Shares - TradingView
How Omnicell Inc. (OC9) stock gains from tech spendingDollar Strength & High Return Trade Opportunity Guides - Newser
Will Omnicell Inc. (OC9) stock keep raising dividendsWeekly Volume Report & Weekly Breakout Opportunity Watchlist - Newser
With Omnicell Stock Surging, Have You Considered The Downside? - Trefis
Aug Swings: Why Omnicell Inc stock could rally in 2025July 2025 Short Interest & Reliable Trade Execution Plans - BỘ NỘI VỤ
Will Omnicell Inc. (OC9) stock beat Nasdaq index returns2025 Investor Takeaways & Safe Investment Capital Preservation Plans - Newser
Will Omnicell Inc. (OC9) stock deliver compounding returns2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - Newser
Is Omnicell Inc. (OC9) stock trading at attractive multiplesBull Run & Technical Pattern Recognition Alerts - Newser
OMCL6251486 Bond Price and Chart — FINRA:OMCL6251486 - TradingView
Omnicell to Host Innovation Update and Q&A Session at Upcoming ASHP Midyear Industry Trade Show - Business Wire
Omnicell (OMCL) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Chmn Lipps Files To Sell 28,250 Of Omnicell Inc [OMCL] - TradingView
Omnicell, Inc. $OMCL Shares Bought by Martin & Co. Inc. TN - MarketBeat
Market Wrap: Is Omnicell Inc. stock a top pick in earnings season2025 Earnings Impact & Accurate Technical Buy Alerts - BỘ NỘI VỤ
Omnicell Stock Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Will Omnicell Inc. stock attract more institutional investors2025 Investor Takeaways & Community Shared Stock Ideas - BỘ NỘI VỤ
A Look At The Fair Value Of Omnicell, Inc. (NASDAQ:OMCL) - Yahoo Finance
What Omnicell (OMCL)'s Upward Earnings Estimate Revisions Mean For Shareholders - Sahm
Rockefeller Capital Management L.P. Reduces Stock Position in Omnicell, Inc. $OMCL - MarketBeat
Wall Street Analysts Think Omnicell (OMCL) Could Surge 30.93%: Read This Before Placing a Bet - sharewise.com
Omnicell, Inc. (OMCL) Stock Forecasts - Yahoo Finance
옴니셀 (OMCL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):